Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

SCD1 is important for hair growth by keeping the connection in skin cells where hair stem cells live stable.

Calorie restriction boosts stem cell activity, improving tissue regeneration and lifespan.

Retinoic acid and DMSO improve gene delivery to mouse skin for potential hair and skin disease treatment.

Tirzepatide may improve hair loss by reducing insulin resistance.

Xinyang Tablet improves heart function in sepsis by reducing inflammation.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Serotonin helps wounds heal faster.

PINK1 is important for controlling gut immune responses linked to early Parkinson's disease.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

Increased energy use in Pik3r1-related insulin resistance isn't due to Ucp1 thermogenesis.

Selenium therapy improved health in cystic fibrosis patients with fewer side effects at a lower dose.

Sinapic acid may protect skin cells from UV damage and reduce inflammation, making it a promising anti-aging cosmetic ingredient.

A group has developed therapies that show promise for treating cancer and various other conditions.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Reducing SFRP1 can promote hair growth and may help treat hair loss.

Overexpressing thrombospondin-1 in mice skin prevents UVB-induced skin damage.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.